Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Percutaneous Coronary Intervention | 6 | 2025 | 299 | 1.630 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2019 | 23 | 0.600 |
Why?
|
| Coronary Stenosis | 1 | 2019 | 78 | 0.570 |
Why?
|
| Drug Utilization | 1 | 2019 | 164 | 0.560 |
Why?
|
| Flecainide | 1 | 2017 | 21 | 0.520 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 887 | 0.470 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 227 | 0.470 |
Why?
|
| Coronary Angiography | 3 | 2024 | 450 | 0.460 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2017 | 362 | 0.420 |
Why?
|
| Heart Ventricles | 2 | 2021 | 749 | 0.410 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 549 | 0.400 |
Why?
|
| Organoids | 3 | 2024 | 305 | 0.360 |
Why?
|
| Acute Coronary Syndrome | 2 | 2025 | 235 | 0.350 |
Why?
|
| Heart Failure | 1 | 2024 | 2332 | 0.330 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 267 | 0.310 |
Why?
|
| Transcatheter Aortic Valve Replacement | 2 | 2025 | 228 | 0.310 |
Why?
|
| ST Elevation Myocardial Infarction | 2 | 2024 | 117 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 2 | 2025 | 350 | 0.290 |
Why?
|
| Stents | 2 | 2024 | 799 | 0.270 |
Why?
|
| Coronary Artery Bypass | 2 | 2023 | 515 | 0.270 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2024 | 32 | 0.210 |
Why?
|
| Asymptomatic Diseases | 1 | 2024 | 77 | 0.210 |
Why?
|
| Virus Replication | 2 | 2024 | 608 | 0.210 |
Why?
|
| Aortic Valve | 2 | 2025 | 455 | 0.210 |
Why?
|
| Endarterectomy, Carotid | 1 | 2024 | 75 | 0.200 |
Why?
|
| Carotid Stenosis | 1 | 2024 | 106 | 0.200 |
Why?
|
| Atherosclerosis | 2 | 2023 | 948 | 0.200 |
Why?
|
| Cross Protection | 1 | 2022 | 10 | 0.180 |
Why?
|
| Treatment Outcome | 6 | 2025 | 12936 | 0.180 |
Why?
|
| Ultrasonography, Interventional | 1 | 2024 | 205 | 0.180 |
Why?
|
| Hepacivirus | 1 | 2023 | 273 | 0.170 |
Why?
|
| Neural Stem Cells | 1 | 2023 | 133 | 0.170 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2023 | 196 | 0.170 |
Why?
|
| Zika Virus | 1 | 2023 | 150 | 0.170 |
Why?
|
| Zika Virus Infection | 1 | 2023 | 173 | 0.160 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2020 | 39 | 0.160 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 59 | 0.160 |
Why?
|
| Protein Interaction Maps | 1 | 2020 | 93 | 0.160 |
Why?
|
| Incidence | 2 | 2025 | 3360 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2023 | 381 | 0.150 |
Why?
|
| Vaccination | 2 | 2022 | 1060 | 0.150 |
Why?
|
| Humans | 19 | 2025 | 131163 | 0.150 |
Why?
|
| Prescriptions | 1 | 2019 | 46 | 0.150 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 67 | 0.140 |
Why?
|
| Office Visits | 1 | 2019 | 80 | 0.140 |
Why?
|
| Thrombolytic Therapy | 1 | 2020 | 191 | 0.140 |
Why?
|
| Aged | 7 | 2024 | 21025 | 0.140 |
Why?
|
| Peripheral Arterial Disease | 1 | 2023 | 326 | 0.140 |
Why?
|
| Bayes Theorem | 1 | 2019 | 311 | 0.130 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2017 | 61 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 237 | 0.130 |
Why?
|
| Prevalence | 1 | 2024 | 2701 | 0.130 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2021 | 425 | 0.130 |
Why?
|
| Echocardiography, Doppler | 1 | 2017 | 158 | 0.130 |
Why?
|
| Risk Factors | 5 | 2025 | 11074 | 0.120 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 1216 | 0.120 |
Why?
|
| Liver | 1 | 2023 | 1796 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2019 | 1483 | 0.120 |
Why?
|
| Medication Adherence | 1 | 2019 | 338 | 0.110 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3061 | 0.110 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1064 | 0.110 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2019 | 729 | 0.110 |
Why?
|
| Biomarkers | 1 | 2024 | 3385 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1797 | 0.110 |
Why?
|
| United States | 5 | 2024 | 12072 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 523 | 0.110 |
Why?
|
| Cardiology | 1 | 2019 | 514 | 0.100 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 744 | 0.090 |
Why?
|
| Veterans | 2 | 2021 | 1763 | 0.090 |
Why?
|
| Registries | 1 | 2019 | 1634 | 0.090 |
Why?
|
| Female | 8 | 2024 | 70963 | 0.090 |
Why?
|
| Middle Aged | 5 | 2024 | 28601 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2025 | 3711 | 0.080 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17753 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2019 | 5063 | 0.080 |
Why?
|
| Antibodies, Neutralizing | 2 | 2022 | 525 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 6797 | 0.060 |
Why?
|
| Male | 6 | 2024 | 64957 | 0.060 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 1176 | 0.060 |
Why?
|
| Time Factors | 2 | 2024 | 6196 | 0.050 |
Why?
|
| Tetraspanins | 1 | 2023 | 30 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2024 | 732 | 0.050 |
Why?
|
| RNA Helicases | 1 | 2023 | 73 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2024 | 440 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2023 | 232 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2022 | 226 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 487 | 0.040 |
Why?
|
| Hospital Bed Capacity | 1 | 2020 | 30 | 0.040 |
Why?
|
| Hospitals, Rural | 1 | 2020 | 16 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2020 | 277 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2020 | 109 | 0.040 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 97 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2024 | 1240 | 0.040 |
Why?
|
| Postoperative Hemorrhage | 1 | 2020 | 83 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1267 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2023 | 282 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2023 | 697 | 0.040 |
Why?
|
| Mothers | 1 | 2022 | 388 | 0.040 |
Why?
|
| Cryoelectron Microscopy | 1 | 2020 | 243 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2020 | 732 | 0.040 |
Why?
|
| Stem Cells | 1 | 2023 | 702 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2020 | 448 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 294 | 0.030 |
Why?
|
| Gestational Age | 1 | 2022 | 1224 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 387 | 0.030 |
Why?
|
| Stroke | 1 | 2024 | 1061 | 0.030 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 802 | 0.030 |
Why?
|
| Sex Factors | 1 | 2020 | 1356 | 0.030 |
Why?
|
| Cytokines | 1 | 2022 | 1339 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2019 | 401 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2020 | 356 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 18301 | 0.030 |
Why?
|
| Comorbidity | 1 | 2020 | 1595 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2825 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 705 | 0.020 |
Why?
|
| Animals | 2 | 2023 | 33912 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 3175 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31282 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 5196 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 10103 | 0.010 |
Why?
|